Quantcast
Last updated on April 18, 2014 at 21:21 EDT

Latest Microbicides Stories

2013-11-14 12:55:19

Research to be presented at world's largest pharmaceutical sciences meeting Researchers developed a first-of-its-kind microbicide gel formulation that shows promise for safe vaginal and rectal administration to prevent the sexual transmission of human immunodeficiency virus (HIV). This research is being presented at the 2013 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition, the world's largest pharmaceutical sciences meeting, in San Antonio, Nov....

New Technology Combining Contraception, HIV And Herpes Simplex Virus-2 Prevention
2013-11-12 12:19:08

CONRAD Multipurpose prevention technologies featured at AAPS Annual Meeting and International Conference on Family Planning CONRAD Head of drug delivery, Meredith Clark, PhD, today presented preclinical data on a new intravaginal ring that provides contraception as well as HIV-1 and HSV-2 prevention at the 2013 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition in San Antonio, Texas. This multipurpose prevention technology (MPT) can remain in the...

2013-10-10 12:29:23

BETHLEHEM, Pa., Oct. 10, 2013 /PRNewswire/ -- Particle Sciences, a drug delivery Contract Development and Manufacturing Organization (CDMO) , has completed the clinical trial manufacturing of vaginal rings with a unique architecture, essentially a powdered filled tube. Designed to deliver the pro-drug tenofovir disoproxil fumarate for 30 days, the device is aimed at HIV prevention and joins several other microbicide delivery approaches under development. The ring provided complete...

HIV Prevention For Women Through New Intravaginal Ring
2013-09-28 05:09:09

April Flowers for redOrbit.com - Your Universe Online The HIV/AIDS epidemic often has a woman's face because the proportion of women infected with HIV has been on the rise for a decade. For example, in sub-Saharan Africa, women constitute 60 percent of people living with disease. Preventative drugs are available, but they are often ineffective, especially in light of financial and cultural barriers in developing nations. The answer, according to a new study published in the Proceedings...

2013-07-23 08:31:48

SAN DIEGO, July 23, 2013 /PRNewswire/ -- Evofem is pleased to announce the early completion of enrollment for their 3,200-subject Phase III registration study of Amphora® non-hormonal contraceptive gel. (Logo: http://photos.prnewswire.com/prnh/20130304/CG70327LOGO) The global trial compares Amphora to Conceptrol®, the brand name of Nonoxynol-9, and the only spermicidal gel currently approved by the FDA. "We are very pleased with the progress on the development of...

Tenofovir Helps Prevent Contraction Of HIV
2013-06-13 13:20:00

Brett Smith for redOrbit.com - Your Universe Online New research from the Centers for Disease Control and Prevention suggests that a daily pill can prevent the contraction of HIV for intravenous drug users. The four-year study, which was published in The Lancet, boosts the argument of those advocating a preventative strategy called “¯pre-exposure prophylaxis, or PrEP. "This is a significant step forward for HIV prevention," Jonathan Mermin, a CDC spokesman who was not...

2013-06-12 16:26:31

AVAC Calls for Accelerated Action to Get PrEP to Those Who Can Benefit From It NEW YORK, June 12, 2013 /PRNewswire-USNewswire/ -- Results from the Bangkok Tenofovir Study published online today in The Lancet provide additional evidence that daily oral tenofovir-based pre-exposure prophylaxis (PrEP) reduces HIV infection risk when taken consistently. The results from the study--the first conducted among people who inject drugs--are consistent with previous studies among men and women...

2013-06-04 08:31:46

WASHINGTON, June 4, 2013 /PRNewswire-USNewswire/ -- At 11:59 p.m. on June 3 the United States Department of Agriculture (USDA) National Organic Program's docket closed, and they ceased taking comments regarding a proposed rule to renew the listing of carrageenan without restriction as an allowed non-synthetic ingredient in U.S. organic foods. While this process is part of a normal five-year review for all ingredients in U.S. organic food, carrageenan has been the subject of considerable...

2013-04-04 12:01:05

A reformulated version of an anti-HIV gel developed for vaginal use was found safe and acceptable by HIV-negative men and women who used it rectally, according to a Phase I clinical trial published today in PLOS ONE. The study, led by researchers with the U.S. National Institutes of Health (NIH)-funded Microbicide Trials Network (MTN), tested a reduced glycerin formulation of tenofovir gel, and has spurred the development of an expanded safety study of the gel, expected to launch later this...

2013-03-04 12:28:19

PrEP Strategies Remain Valuable Prevention Tool, says AVAC NEW YORK, March 4, 2013 /PRNewswire-USNewswire/ -- Results from a large-scale HIV prevention trial among African women known as VOICE (Vaginal and Oral Interventions to Control the Epidemic) provide an urgent reminder that products must meet the needs of the people using them. While disappointing, the results lend new urgency and direction to the search for additional safe and effective HIV prevention options for women, AVAC said...